Skip to main content
. 2019 Sep 24;20(5):4533–4539. doi: 10.3892/mmr.2019.10699

Figure 2.

Figure 2.

Upregulation of plasma LINC01638 can distinguish patients with PDAC from healthy controls. (A) Plasma levels of LINC01638 were significantly higher in PDAC patients than in healthy controls and (B) upregulation of plasma LINC01638 distinguished PDAC patients from healthy controls in receiver operating characteristic (*P<0.05). PDAC, pancreatic ductal adenocarcinoma.